Sample | Sex | Age (Years) | Clinical status | Clonality featuers | Proviral load (copies/1000 PBMCs) | Total input reads | Total filtered reads (%) | Mapped reads |
---|---|---|---|---|---|---|---|---|
131ASP | Female | 52 | Asymptomatic | Polyclonal | 17 | 4,029,944 | 781,412 (19,39%) | 3,248,532 |
146ASP | Female | 59 | Asymptomatic | Polyclonal | 208 | 12,762,102 | 2,906,807 (22,78%) | 9,855,295 |
151ASP | Female | 72 | Asymptomatic | Polyclonal | 1 | 11,798,500 | 1,847,981 (15,66%) | 9,950,519 |
152ASP | Female | 34 | Asymptomatic | Polyclonal | 60 | 6,451,236 | 904,790 (14,03%) | 5,546,446 |
167ASP | Female | 58 | Asymptomatic | Polyclonal | 32 | 5,947,163 | 953,127 (16,03%) | 4,994,036 |
172ASP | Female | 31 | Asymptomatic | Polyclonal | 102 | 4,454,137 | 737,503 (16,56%) | 3,716,634 |
182ASP | Female | 80 | Asymptomatic | Polyclonal | 22 | 7,316,342 | 1,431,104 (19,56%) | 5,885,238 |
188ASP | Female | 49 | Asymptomatic | Polyclonal | 8 | 9,232,541 | 2,325,497 (25,19%) | 6,907,044 |
001ATLL | Female | 65 | Lymphomatous | Monoclona | 3297 | 7,344,758 | 1,914,409 (26,06%) | 5,430,349 |
005ATLL | Male | 73 | Chronic | Monoclona | 207 | 5,482,002 | 1,487,974 (27,14%) | 3,994,028 |
007ATLL | Male | 58 | Chronic | Monoclona | 283 | 8,320,364 | 2,056,148 (24,71%) | 6,264,216 |
017ATLL | Female | 35 | Chronic | Monoclona | 104 | 9,024,187 | 2,474,763 (27,42%) | 6,549,424 |
171ATLL | Male | 56 | Acute | Monoclona | 957 | 4,030,123 | 209,221 (5,19%) | 3,820,902 |
227ATLL | Female | 24 | Acute | Monoclona | 4482 | 2,473,707 | 210,428 (8,51%) | 2,263,279 |
238ATLL | Male | 34 | Acute | Monoclona | 2277 | 2,067,310 | 187,676 (9,08%) | 1,879,634 |
269ATLL | Male | 43 | Acute | Monoclona | 846 | 8,771,571 | 345,333 (3,94%) | 8,426,238 |
275ATLL | Female | 34 | Acute | Monoclona | 508 | 5,497,660 | 200,073 (3,64%) | 5,297,587 |
342ATLL | Female | 39 | Acute | Monoclona | 898 | 6,977,352 | 750,867 (10,76%) | 6,226,485 |
002HC | Female | 38 | HC | ND | NA | 3,716,097 | 430,662 (11,59%) | 3,285,435 |
003HC | Male | 53 | HC | ND | NA | 8,962,210 | 910,815 (10,16%) | 8,051,395 |
004HC | Female | 37 | HC | ND | NA | 5,086,522 | 845,267 (16,62%) | 4,241,255 |
005HC | Male | 32 | HC | ND | NA | 2,978,098 | 473,954 (15,91%) | 2,504,144 |
006HC | Female | 32 | HC | ND | NA | 6,700,098 | 866,374 (12,93%) | 5,833,724 |